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for type C stenoses, a 61% success and a 21% complication rate. The subdivision into types Bi and B2 provided significantly more information in this clinically importantintermediate risk group than did the standard ACC/AHA scheme. The stenosis characteristics of chronic total occlusion, highgrade (80-99% diameter) stenosis, stenosis bend of more than 60°, and excessive tortuosity were particularly predictive of adverse procedural outcome. This improved scheme may improve clinical decision making and provide a framework on which to base meaningful subgroup analysis in randomized trials assessing the efficacy of percutaneous coronary angioplasty. (Circulation 1990; 82:1193 -1202 T he clinical and anatomic heterogeneity of short-and long-term outcomes with percutaneous patients with multivessel coronary artery discoronary angioplasty (PTCA). Previous short-term ease might expectedly lead to differences in follow-up studies have focused on the feasibility and relative safety of PTCA in selected patients withmultivessel involvement. As in the 1985-1986 report from the National Heart, Lung, and Blood Institute See p 1516 (NHLBI) PTCA Registry, which found major complications in 9.5% of patients with multivessel disease compared with 5% of patients with single-vessel disease,1 most reports have found the risk of PTCA to be somewhat higher in patients with multivessel,2-8 compared with single-vessel, coronary artery disease.' Coronary angioplasty therefore may not be the best form of therapy for all patients with multivessel coronary disease. An increased understanding of the clinical9-11 and anatomic12-15 substrates predisposing patients to acute complications of angioplasty has led to an attempt by the American College of Cardiology and the American Heart Association (ACC/AHA) to systematize the characterization of stenoses considered for coronary angioplasty.16This schema has never been formally validated.
Therefore, to aid in choosing appropriate therapy and to provide a rational basis for subgroup analysis in ongoing or anticipated randomized trials, we applied ACC/AHA and other criteria to 350 consecutive patients with multivessel disease undergoing PTCA to ascertain how short-term outcome might best be predicted.
Methods

Patient Population
Cineangiograms from 100 consecutive patients with stable or unstable angina and multivessel coronary disease (see definitions) undergoing attempted PTCA on or after January 1, 1986, were requested from each of the four participating institutions. Patients with prior coronary bypass surgery or acute myocardial infarction were excluded, and only patients with a life expectancy of .1 year were included. Such patients reflected those accepted for coronary angioplasty at each of the clinical sites in 1986 and 1987. Due to a change of study personnel at one clinical center, only 50 qualifying patients were enrolled from that site, and thus results from 350 patients were analyzed.
Angioplasty Procedure
The technique of angioplasty used has been described elsewhere.'7 All patients were pretreated with oral aspirin (80-325 mg daily) and intravenous heparin (10,000 units at the beginning of the procedure). 
Angiographic Analysis
One of two experienced angiographers at the Angiographic Core Laboratory reviewed the diagnostic and procedural angiograms to determine suitability for study entry and to code for 18 lesion-specific characteristics and 18 patient variables without knowledge of clinical outcome. All quantitative measurements were made using hand-held calipers in orthogonal projections at end-diastole, when possible. Thirty patients were excluded from the study due to non-visualization of a contralateral (e.g., the right coronary artery, when angioplasty was performed in the left anterior descending coronary artery) coronary artery (n= 17), the presence of single-vessel disease (n = 7), inadequate stenosis visualization (n=4), and angioplasty not performed during the study period (n=2). Additional patients were then requested until each institution's quota was met.
The following angiographic definitions, based upon those used in the National Heart, Lung, and Blood Institute Bypass Angioplasty Revascularization Investigation (BARI) (BARI Central Radiographic Laboratory Operations Manual, unpublished), were used: ACC/AHA Task Force stenosis characteristic type.
The scheme elaborated in Table 1 Reproduced with permission of the American Heart Association, the American College of Cardiology, and the author. 16 the purposes of statistical analysis, type A stenoses were coded 1 point, type B stenoses were coded 2 points, and type C stenoses were coded 3 points.
Bifurcation stenosis. The stenosis was recorded as a bifurcation stenosis if a branch vessel of medium or large size originated within the stenosis and if the side branch was completely surrounded by significant stenotic portions of the lesion to be dilated.
Calcification. Calcification was recorded if readily apparent densities were seen within the apparent vascular wall of the artery at the site of the stenosis.
Chronic total occlusion. A total occlusion (thrombolysis in myocardial infarction [TIMI] flow grade 018), judged to be .3 months duration on the basis of clinical and angiographic findings, was coded as a chronic total occlusion. Eccentric stenosis. A stenosis was classified as eccentric when its lumen was in the outer onequarter diameter of the apparent normal lumen.
High grade stenosis. A high-grade stenosis was defined as a diameter narrowing of 80-99% relative to the adjacent normal coronary artery dimension.
Irregular contour. A stenosis was classified as having irregular contour if the vascular margin was rough or had a "sawtooth" appearance.
Jeopardized terntory. All terminal (e.g., distal left anterior descending, diagonal branch) branches of the coronary tree were scored small, moderate, or large depending on their vascular distribution. A medium-sized branch was defined as one that extended 1/4 to 2/3 of the distance from base to apex of the left ventricle in a projection that best elongated the branch. Large and small terminal branches were defined as longer and shorter, respectively, although branches of diameter <1.0 mm were generally considered absent. Branches scored as small were assigned 1 point, branches scored as moderate were assigned 2 points, and branches scored as large were assigned 3 points. The jeopardized territory equalled the sum of branches distal to the stenosis dilated, divided by the sum of all terminal branches of the coronary tree.19 For example, the jeopardized territory for a mid-left anterior descending coronary artery stenosis with moderate-sized distal left anterior descending and moderate-sized diagonal branch beyond the stenosis, would be 2+2=4, divided by the sum of all branches of the coronary tree.
Lesion length. Lesion length was measured by caliper as the distance from the proximal to distal shoulder of the lesion in the projection that best elongated the stenosis. Stenoses of 10-20 mm length were defined as tubular, and those of >20 length were defined as diffuse.
Modified ACCIAHA score. The standard ACC/ AHA score was prospectively modified to subdivide type B stenoses into Bi (one adverse characteristic) and B2 (>two adverse characteristics) on the basis of prior work suggesting the cumulative importance of multiple adverse lesion characteristics.14 For the purpose of statistical analysis, type A stenoses were coded 1 point, type Bi stenoses 2 points, type B2 stenoses 3 points, and type C stenoses 4 points.
Multivessel disease. Multivessel coronary disease was defined as the presence of a >50% diameter stenosis in two of the three major epicardial coronary vessels, or surgically bypassable branches thereof. When the right coronary artery was nondominant and failed to supply any left ventricular myocardium, the first two moderate-or large-sized obtuse marginal branches of the circumflex were considered to supply one vascular territory, and the distal obtuse marginal branches and the posterior descending coronary artery were said to supply a different vascular territory.
Ostial stenoses. A stenosis was classified as "ostial" when it involved the origin of the proximal left anterior descending, left circumflex, or right coronary arteries. When they occurred together, "ostial" and "bifurcation" were counted as only one ACC/AHA class B characteristic.
Other stenoses. A stenosis was classified as associated with other stenoses when other >50% stenoses were found in the same or adjacent (BARI classification) coronary segment.
Primary target stenosis. A primary target stenosis was identified on the basis of the severity and morphologic characteristics of the stenoses,20 their jeopardized territories, the presumed viability of the myocardium subserved, and clinical data when available.
Segmental contractility. Segmental left ventricular myocardial contractility was scored normal equal to 3 points, mildly hypokinetic equal to 2 points, severely hypokinetic equal to 1 point, and akinetic or dyskinetic equal to 0 points. Stenosis angle. The vessel angle formed by a centerline through the lumen proximal to the stenosis and extending beyond it and a second centerline in the straight portion of the artery distal to stenosis was measured in a nonforeshortened view at end-diastole.
Successful dilatation (stenosis success). A successful dilation was defined as a final result <50% diameter stenosis associated with no major adverse clinical sequelae (death, myocardial infarction, or emergency bypass surgery).
Thrombus. A thrombus was scored if an intraluminal filling defect, largely separated from the adjacent vessel wall, was clearly definable.
Tortuosity. The difficulty in accessing the stenosis to be dilated due to tortuosity proximal to its site was assessed. Stenoses distal to two bends were, in general, scored as moderately tortuous, and those distal to three or more bends were considered to be associated with excessive tortuosity.
Several combined variables were also assessed: Primary target stenosis ACC/AHA score. Sum of all stenoses (250%) ACC/AHA scores. Primary target stenosis modified ACC/AHA scores.
Sum of all stenoses modified ACC/AHA scores.
Primary target stenosis modified ACC/AHA score xjeopardized territory.
Sum of all stenoses' modified ACC/AHA scores x their respective jeopardized territories.
Primary target stenosis modified ACC/AHA score xjeopardized territoryx segmental contractility.
Sum of all stenoses' modified ACC/AHA scores x jeopardized territoryx segmental contractility.
Procedural Outcome
Procedural outcome was assessed at the Data Coordinating Center using data supplied by the individual clinical sites. The following definitions were used:
Procedural success. Reduction in diameter stenosis in one or more stenosis to <50% stenosis associated with no major ischemic complications during hospitalization.
Procedure-related myocardial infarction. Myocardial infarction defined by cardiac enzymes or electrocardiographic changes resulting from procedureinduced ischemia.
Procedure-related death. Death resulting from attempted PTCA.
Procedure-related complications. Death, emergency bypass surgery, or myocardial infarction resultant from attempted PTCA.
Stenosis-related outcomes. Stenosis-related outcomes were defined in a similar manner, except that outcome was related directly to the stenosis(es) dilated. In the event an adverse event could not be related to outcome at a given stenosis, the core angiographer assigned the outcome to the most likely stenosis. This was very infrequently required (see results).
Statistical Analysis
All data were entered in the MAPS Databank at the Data Coordinating Center. Data are expressed as mean± 1 SD unless otherwise indicated. x2 analyses 
Results
Patient and Stenosis Characteristics
Cineangiograms from 350 patients (1,100 stenoses) were analyzed. The characteristics of the study patients and the stenosis dilated are given in Tables  2 and 3 , respectively. Of importance, 72% of the patients had severe (Canadian Cardiovascular Society Class III or IV) angina, the majority of patients (78%) had two-vessel coronary disease, left ventricular function was usually well preserved (ejection fraction, 58+12%), and 1.9 stenoses per patient were dilated. The stenoses dilated were of mixed complexity, with 29% having characteristics suggestive of expected high success and low complication rates (ACC/AHA type A), 61% having characteristics of expected moderate success and complication rates (ACC/AHA type B), and 10% having low success and high-risk characteristics (ACC/AHA type C). All but one (99.7%) of the core lab-determined primarytarget stenoses had attempted angioplasty. Overall Procedural Outcome Two hundred ninety of 350 patients (82.6%) had at least one stenosis successfully dilated and no major ischemic complications. An additional nine patients (2.6%) had a reduction in diameter stenosis of one or tics, only stenosis eccentricity and high-grade stenosis had no apparent relation to the likelihood of complications (relative risk<1.0).
Correlates of Procedural Success
Selective univariate (including all variables with p0.15) and all independent predictors of procedural success are shown in Table 5A . The modified ACC/AHA score of the primary-target stenosis (univariate p=0.002) and the absence of diabetes mellitus (univariate p=0.007) were both strongly correlated with, and the only independent predictors of, procedural success. When the primary-target stenosis was type A, 91% of procedures were successful; when the target stenosis was type Bi, 86% of procedures were successful; when the target stenosis was type B2, 79% of procedures were successful; and when the target stenosis was type C, only 68% of procedures were successful. Procedural success was achieved in 74% of diabetic patients compared with 87% of nondiabetic patients.
Correlates of Procedural Complications
Selected univariate and all independent predictors of procedural complications are shown in Table SB . Again, the modified ACC/AHA score of the primarytarget stenosis and the presence of diabetes were the only independent predictors of complications. When the primary-target stenosis was type A, complications occurred in 2.4% of patients; when it was type Bi, complications occurred in 8% of patients; when it was type B2, complications occurred in 10% of patients; and when it was type C, complications occurred in 17.5% of patients. Complications occurred in 15.4% of diabetic patients, compared with 5.8% of nondiabetic patients.
Interobserver Variability
For the 57 stenoses analyzed, there was complete agreement in 33 (58%), disagreement by one classification (e.g., A or B2 compared with B1) in 20 (35%), disagreement by two classification units in heart failure,9 unstable angina,9 and multivessel coroComparative randomized data on the efficacy of nary disease.22 It would have to be presumed that coronary angioplasty versus bypass surgery in such these adverse risk factors might well be important in patients will not be available until the 1990s. Even patients with multivessel disease, but their overall then, overall results may not be directly applicable for impact has not been defined in this population. These any given individual patient, and at present such trials factors have been amalgamated into the recently lack adequate background information on which to published ACC/AHA Task Force report (see Table  base reasonable and statistically meaningful subgroup 1), yet this scheme is largely untested at present. In the analyses. Recent studies assessing the results of corocurrent study, 1,100 stenoses (662 of which were nary angioplasty in patients with multivessel disease dilated) from 350 consecutively treated patients were have found procedural success rates of 84-95%4-6 evaluated to determine prospective determinants of and complication rates of 2-9%.'-5 These results procedural outcome. Procedural success was achieved reflect the composite outcome in a selected yet hetin 85% of patients and major complications (death, When this four-tier schema was applied to each patient's primary target stenosis, it was the most powerful predictor of overall procedural outcome of any variable tested (p<0.001 for both success and complications). Importantly, none of the traditional discriminators of outcome in patients with coronary disease, in particular the number of diseased vessels, predicted outcome (stenosis success in two-vessel disease was 82.4%, in three-vessel disease, 83.9%; complications in two-vessel disease were 8.0%, in threevessel disease 9.8%).
The impact on procedural outcome of each individual component defining a type B or type C stenosis is not equal. Despite the fact this study is the largest of its kind, it lacks statistical power to adequately differentiate the relative importance of several variables, particularly when they occur at a low frequency in the study group. However, even when the modified ACC/ AHA score was considered, the variable high-grade stenosis (80-99% diameter stenosis by calipers, roughly corresponding to 90-99% by visual inspection19) imparted a highly significant lower likelihood of success (p =0.004). Of all the morphologic variables tested, only stenosis eccentricity had no relation to success or complications. These data suggest, therefore, that highgrade stenosis should be added and stenosis eccentricity can be deleted from the list of type B characteristics. Furthermore, the variables diabetes mellitus, chronic total occlusion, stenosis bend >600, excessive tortuosity, and bifurcation stenosis still imparted significant prognostic information beyond that supplied by the four-tier stratification system and should be regarded as particularly important prognostic characteristics. A useful estimate of the likelihood of success or complications from these data for any individual clinical situation may be made by simple addition of the coefficients for variables listed in Tables 4A and 4B  ( 
Limitations
In considering these results, certain limitations of the study should be considered. First, the majority of these patients had two-vessel coronary disease and well-preserved left ventricular function and do not reflect the distribution of coronary artery involvement and functional impairment of all patients with multivessel coronary disease. 24 In patients with a larger number of severe stenoses, the importance of the morphology of the primary target stenosis relative to that of all, or multiple, stenoses would be expected to decrease. Second, assessment of coronary artery morphology is subjective,14 and the use of these data to assist in clinical decision making will require strict attention to the details of the definitions used. Given the multiplicity of morphologic criteria evaluated in the modified ACC/AHA system, it is not surprising that variability in its assessment was noted. Variation by one classification (e.g., A or B2 compared with B1) was observed in 35% of lesions. However, variation by more than one classification, which would have a much greater impact on the assessment of prognosis, was uncommon. Nonetheless, interobserver variability must be recognized as a major limitation to this method. Third, the method of defining primary target stenosis was somewhat arbitrary. Nonetheless, all but one of the core lab-determined primary-target stenoses had attempted angioplasty. Fourth, the multiple comparisons made increase the likelihood of observing a spurious correlation. Prospective evaluation of this scheme in a large validation sample would be useful. Fifth, conclusions regarding suitability of patients for coronary angioplasty must also consider comparative long-term efficacies with other forms of treatment, and little data are available in this regard.6'25-27 Sixth, this is not a randomized comparison of treatments, and definitive statements regarding the efficacy of PTCA versus bypass surgery must await carefully randomized comparisons of prospectively defined subgroups of patients in this heterogeneous population. Finally, improved results with angioplasty may result from use of the now available, somewhat lower profile balloons, or the concomitant use of intracoronary stents,28 laser balloon angioplasty,29 and other evolving adjunctive techniques.
Nonetheless, these data suggest good short-term results can be obtained with coronary angioplasty performed by experienced operators in patients with multivessel disease in whom the important stenosis(es) has type A or B1 characteristics. However, when the important stenoses have type B2 or type C characteristics, particularly in the presence of diabetes, chronic total occlusion, bend >600, high-grade stenosis, or excessive tortuosity subserving a large mass of viable myocardium, the results suggest other forms of revascularization be very strongly considered. These data also provide the framework upon which to base prospective subgroup evaluation in randomized trials comparing standard coronary angioplasty to other treatment modalities in patients with multivessel coronary disease.
